Los puntos clave no están disponibles para este artículo en este momento.
Our study aims to determine whether myostatin (MSTN) is associated with muscle mass and strength in individuals with cancer or obesity, as well as with cancer cachexia (CC) or sarcopenic obesity (SO).
Orioli et al. (Fri,) studied this question.